Anand Rathi is Bullish on Pfizer India recommends Buy
Anand Rathi has given Buy recommendation for Pfizer India with a target price of Rs. 5655 in its research report…
Anand Rathi has given Buy recommendation for Pfizer India with a target price of Rs. 5655 in its research report…